CORMCO • Patient Capital & Superior Returns

CORMCO • Patient Capital & Superior Returns

إدارة الاستثمارات

Beirut، Beirut Governate ١٬٩٢٥ متابع

Public and private investments in the global tech, biotech, and real estate industries since 1998

نبذة عنا

CORMCO ® is a private investment company focused on public and private companies in the global tech, biotech, and real estate industries. Founded in 1998, CORMCO was an early investor in top companies, such as Broadcom and Nvidia, and continues to be a proactive investor in more recent, both public and private, tech companies in the AI, big data, cloud computing, IoT, machine learning, SaaS, and software industries. CORMCO is also an active biotech investor in the biopharma, genetics, life science, medical device, and therapeutics industries. Finally, CORMCO makes and holds real estate investments in order to generate passive rental income, produce capital appreciation, and mitigate its overall portfolio volatility. From 1999 to 2024, CORMCO's net asset value (NAV) increased by 203,000%.

الموقع الإلكتروني
http://www.cormco.com
المجال المهني
إدارة الاستثمارات
حجم الشركة
١١- ٥٠ موظف
المقر الرئيسي
Beirut, Beirut Governate
النوع
شركة يملكها عدد قليل من الأشخاص
تم التأسيس
1998
التخصصات
Investments، Finance، Technology، Biotechnolgy، و Real Estate

المواقع الجغرافية

موظفين في CORMCO • Patient Capital & Superior Returns

التحديثات

  • عرض صفحة منظمة CORMCO • Patient Capital & Superior Returns، رسم بياني

    ١٬٩٢٥ متابع

    Nvidia • CORMCO's Top Holding since 1999 Patient capital in action. Nvidia is our top holding since its IPO in 1999 (up 338,850%). From IPO to most valuable company in the world (3.34 trillion USD market cap). 25 years in the making. ✨ #cormco #patientcapital #superiorreturns CORMCO ® is a private investment company focused on public and private companies in the global tech, biotech, and real estate industries. Founded in 1998, CORMCO was an early investor in top companies, such as Broadcom and Nvidia, and continues to be a proactive investor in more recent, both public and private, tech companies in the AI, big data, cloud computing, IoT, machine learning, SaaS, and software industries. CORMCO is also an active biotech investor in the biopharma, genetics, life science, medical device, and therapeutics industries. Finally, CORMCO makes and holds real estate investments in order to generate passive rental income, produce capital appreciation, and mitigate its overall portfolio volatility. From 1999 to 2024, CORMCO's net asset value (NAV) increased by 203,000%.

    • CORMCO ® is a private investment company focused on public and private companies in the global tech, biotech, and real estate industries. Founded in 1998, CORMCO was an early investor in top companies, such as Broadcom and Nvidia, and continues to be a proactive investor in more recent, both public and private, tech companies in the AI, big data, cloud computing, IoT, machine learning, SaaS, and software industries. CORMCO is also an active biotech investor in the biopharma, genetics, life science, medical device, and therapeutics industries. Finally, CORMCO makes and holds real estate investments in order to generate passive rental income, produce capital appreciation, and mitigate its overall portfolio volatility. From 1999 to 2024, CORMCO's net asset value (NAV) increased by 203,000%.
  • عرض صفحة منظمة CORMCO • Patient Capital & Superior Returns، رسم بياني

    ١٬٩٢٥ متابع

    Corm & Co is a conglomerate founded by Charles Corm (1894 to 1963) in 1929. It was the exclusive agent of Ford Motor Company for the Greater Middle East region. It also acquired sizable equity in companies such as Ford, GM, and GE. CORMCO ® is a private investment company focused on public and private companies in the global tech, biotech, and real estate industries. Founded in 1998, CORMCO was an early investor in top companies, such as Broadcom and Nvidia, and continues to be a proactive investor in more recent, both public and private, tech companies in the AI, big data, cloud computing, IoT, machine learning, SaaS, and software industries. CORMCO is also an active biotech investor in the biopharma, genetics, life science, medical device, and therapeutics industries. Finally, CORMCO makes and holds real estate investments in order to generate passive rental income, produce capital appreciation, and mitigate its overall portfolio volatility. From 1999 to 2024, CORMCO's net asset value (NAV) increased by 203,000%. #cormco #legacy #patientcapital #superiorreturns #investments

    • CORMCO ® is a private investment company focused on public and private companies in the global tech, biotech, and real estate industries. Founded in 1998, CORMCO was an early investor in top companies, such as Broadcom and Nvidia, and continues to be a proactive investor in more recent, both public and private, tech companies in the AI, big data, cloud computing, IoT, machine learning, SaaS, and software industries. CORMCO is also an active biotech investor in the biopharma, genetics, life science, medical device, and therapeutics industries. Finally, CORMCO makes and holds real estate investments in order to generate passive rental income, produce capital appreciation, and mitigate its overall portfolio volatility. From 1999 to 2024, CORMCO's net asset value (NAV) increased by 203,000%.
  • عرض صفحة منظمة CORMCO • Patient Capital & Superior Returns، رسم بياني

    ١٬٩٢٥ متابع

    The key to long-term success is a 5 step approach that entails patience and strategic rebalancing of portfolio weightings. CORMCO ® is a private investment company focused on public and private companies in the global tech, biotech, and real estate industries. Founded in 1998, CORMCO was an early investor in top companies, such as Broadcom and Nvidia, and continues to be a proactive investor in more recent, both public and private, tech companies in the AI, big data, cloud computing, IoT, machine learning, SaaS, and software industries. CORMCO is also an active biotech investor in the biopharma, genetics, life science, medical device, and therapeutics industries. Finally, CORMCO makes and holds real estate investments in order to generate passive rental income, produce capital appreciation, and mitigate its overall portfolio volatility. From 1999 to 2024, CORMCO's net asset value (NAV) increased by 203,000%. #cormco #patientcapital #superiorreturns #investments #success

    • لا يوجد نص بديل لوصف هذه الصورة
  • عرض صفحة منظمة CORMCO • Patient Capital & Superior Returns، رسم بياني

    ١٬٩٢٥ متابع

    CORMCO's net asset value (NAV) is calculated based on the net asset values of its public and private investments. CORMCO's revenue is the aggregate revenue of rental income stemming from portfolio properties, dividends paid out by portfolio companies, and capital gains associated with portfolio liquidity events. CORMCO carries no debt and no leverage. CORMCO ® is a private investment company focused on public and private companies in the global tech, biotech, and real estate industries. Founded in 1998, CORMCO was an early investor in top companies, such as Broadcom and Nvidia, and continues to be a proactive investor in more recent, both public and private, tech companies in the AI, big data, cloud computing, IoT, machine learning, SaaS, and software industries. CORMCO is also an active biotech investor in the biopharma, genetics, life science, medical device, and therapeutics industries. Finally, CORMCO makes and holds real estate investments in order to generate passive rental income, produce capital appreciation, and mitigate its overall portfolio volatility. From 1999 to 2024, CORMCO's net asset value (NAV) increased by 203,000%. #cormco #patientcapital #superiorreturns #investments

    • CORMCO ® is a private investment company focused on public and private companies in the global tech, biotech, and real estate industries. Founded in 1998, CORMCO was an early investor in top companies, such as Broadcom and Nvidia, and continues to be a proactive investor in more recent, both public and private, tech companies in the AI, big data, cloud computing, IoT, machine learning, SaaS, and software industries. CORMCO is also an active biotech investor in the biopharma, genetics, life science, medical device, and therapeutics industries. Finally, CORMCO makes and holds real estate investments in order to generate passive rental income, produce capital appreciation, and mitigate its overall portfolio volatility. From 1999 to 2024, CORMCO's net asset value (NAV) increased by 203,000%.
  • عرض صفحة منظمة CORMCO • Patient Capital & Superior Returns، رسم بياني

    ١٬٩٢٥ متابع

    CORMCO's mission is to deploy patient capital and generate superior long-term investment returns while embracing stringent risk management methodologies. CORMCO makes and holds real estate investments in order to generate passive rental income, produce capital appreciation, and mitigate our overall portfolio volatility (Beta). CORMCO is also invested in US technology and biotechnology venture capital funds managed by Sequoia Capital, Accel, and Kleiner Perkins since 2003. CORMCO ® is a private investment company focused on public and private companies in the global tech, biotech, and real estate industries. Founded in 1998, CORMCO was an early investor in top companies, such as Broadcom and Nvidia, and continues to be a proactive investor in more recent, both public and private, tech companies in the AI, big data, cloud computing, IoT, machine learning, SaaS, and software industries. CORMCO is also an active biotech investor in the biopharma, genetics, life science, medical device, and therapeutics industries. Finally, CORMCO makes and holds real estate investments in order to generate passive rental income, produce capital appreciation, and mitigate its overall portfolio volatility. From 1999 to 2024, CORMCO's net asset value (NAV) increased by 203,000%. #cormco #patientcapital #superiorreturns #investments

    • لا يوجد نص بديل لوصف هذه الصورة
  • عرض صفحة منظمة CORMCO • Patient Capital & Superior Returns، رسم بياني

    ١٬٩٢٥ متابع

    CORMCO was, as of January 2024, 65% invested in global technology and biotechnology public equity, 14% invested in global venture capital funds, 13% invested in global technology and biotechnology private equity, 5% invested in global real estate, and 3% invested in global fixed-income securities. CORMCO ® is a private investment company focused on public and private companies in the global tech, biotech, and real estate industries. Founded in 1998, CORMCO was an early investor in top companies, such as Broadcom and Nvidia, and continues to be a proactive investor in more recent, both public and private, tech companies in the AI, big data, cloud computing, IoT, machine learning, SaaS, and software industries. CORMCO is also an active biotech investor in the biopharma, genetics, life science, medical device, and therapeutics industries. Finally, CORMCO makes and holds real estate investments in order to generate passive rental income, produce capital appreciation, and mitigate its overall portfolio volatility. From 1999 to 2024, CORMCO's net asset value (NAV) increased by 203,000%. #cormco #patientcapital #superiorreturns #investments

    • لا يوجد نص بديل لوصف هذه الصورة
  • عرض صفحة منظمة CORMCO • Patient Capital & Superior Returns، رسم بياني

    ١٬٩٢٥ متابع

    90% of traders fail to implement a solid risk management plan and take on more risk than they can handle. This can lead to significant losses that wipe out their trading capital and leave little to show for their efforts. CORMCO ® is a private investment company focused on public and private companies in the global tech, biotech, and real estate industries. Founded in 1998, CORMCO was an early investor in top companies, such as Broadcom and Nvidia, and continues to be a proactive investor in more recent, both public and private, tech companies in the AI, big data, cloud computing, IoT, machine learning, SaaS, and software industries. CORMCO is also an active biotech investor in the biopharma, genetics, life science, medical device, and therapeutics industries. Finally, CORMCO makes and holds real estate investments in order to generate passive rental income, produce capital appreciation, and mitigate its overall portfolio volatility. From 1999 to 2024, CORMCO's net asset value (NAV) increased by 203,000%. #patientcapital #notrading #superiorreturns

    • لا يوجد نص بديل لوصف هذه الصورة
  • عرض صفحة منظمة CORMCO • Patient Capital & Superior Returns، رسم بياني

    ١٬٩٢٥ متابع

    While Buffett doesn’t always follow the crowd when it comes to investment choices, he does have exposure in three out of the five “FAANG” stocks (Facebook, Amazon, Apple, Netflix, and Google) through NEAM. These large-cap tech stocks are all household names. You don’t have to be an expert in artificial intelligence or quantum computing to see the impact Alphabet (or Apple and Amazon, in which NEAM also holds shares) will have on the future. CORMCO ® is a private investment company focused on public and private companies in the global tech, biotech, and real estate industries. Founded in 1998, CORMCO was an early investor in top companies, such as Broadcom and Nvidia, and continues to be a proactive investor in more recent, both public and private, tech companies in the AI, big data, cloud computing, IoT, machine learning, SaaS, and software industries. CORMCO is also an active biotech investor in the biopharma, genetics, life science, medical device, and therapeutics industries. Finally, CORMCO makes and holds real estate investments in order to generate passive rental income, produce capital appreciation, and mitigate its overall portfolio volatility. From 1999 to 2024, CORMCO's net asset value (NAV) increased by 203,000%. #cormco #patientcapital #superiorreturns #investments

    These Are the 5 Tech Stocks in Warren Buffett’s Portfolio: Should You Invest?

    These Are the 5 Tech Stocks in Warren Buffett’s Portfolio: Should You Invest?

    finance.yahoo.com

  • عرض صفحة منظمة CORMCO • Patient Capital & Superior Returns، رسم بياني

    ١٬٩٢٥ متابع

    Investing in a tech ETF or mutual fund will offer you more diversification which can better help hedge against risk than if you were to select individual stocks. Additionally, investments in ETFs or mutual funds can potentially be more affordable since some tech companies have extremely high share prices. CORMCO ® is a private investment company focused on public and private companies in the global tech, biotech, and real estate industries. Founded in 1998, CORMCO was an early investor in top companies, such as Broadcom and Nvidia, and continues to be a proactive investor in more recent, both public and private, tech companies in the AI, big data, cloud computing, IoT, machine learning, SaaS, and software industries. CORMCO is also an active biotech investor in the biopharma, genetics, life science, medical device, and therapeutics industries. Finally, CORMCO makes and holds real estate investments in order to generate passive rental income, produce capital appreciation, and mitigate its overall portfolio volatility. From 1999 to 2024, CORMCO's net asset value (NAV) increased by 203,000%. #cormco #patientcapital #superiorreturns #investments

    Investing in the tech sector? Here’s what you need to know

    Investing in the tech sector? Here’s what you need to know

    chase.com

  • عرض صفحة منظمة CORMCO • Patient Capital & Superior Returns، رسم بياني

    ١٬٩٢٥ متابع

    A great article about tech investments from the corporate finance perspective. Some good case studies too. CORMCO ® is a private investment company focused on public and private companies in the global tech, biotech, and real estate industries. Founded in 1998, CORMCO was an early investor in top companies, such as Broadcom and Nvidia, and continues to be a proactive investor in more recent, both public and private, tech companies in the AI, big data, cloud computing, IoT, machine learning, SaaS, and software industries. CORMCO is also an active biotech investor in the biopharma, genetics, life science, medical device, and therapeutics industries. Finally, CORMCO makes and holds real estate investments in order to generate passive rental income, produce capital appreciation, and mitigate its overall portfolio volatility. From 1999 to 2024, CORMCO's net asset value (NAV) increased by 203,000%. #cormco #patientcapital #superiorreturns #investments

    Technology Investment Strategies for Business Success | CFO.University

    Technology Investment Strategies for Business Success | CFO.University

    cfo.university

صفحات مشابهة